148 related articles for article (PubMed ID: 9484672)
21. [Detection of prostate cancer in urological practice: clinical establishment of serum PSA reference values by age].
Yamazaki H; Suzuki Y; Madarame A; Katoh N; Masuda F; Ohishi ; Endo K
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):702-9. PubMed ID: 8709448
[TBL] [Abstract][Full Text] [Related]
22. Total and free PSA: a methodical and clinical evaluation of five assays.
Reiter W; Stieber P; Schmeller N; Nagel D; Hofmann K; Fateh-Moghadam A
Anticancer Res; 1997; 17(6D):4759-65. PubMed ID: 9494603
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
24. Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique.
Yu H; Diamandis EP
J Urol; 1995 Mar; 153(3 Pt 2):1004-8. PubMed ID: 7531781
[TBL] [Abstract][Full Text] [Related]
25. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications.
Jung K; Brux B; Lein M; Rudolph B; Kristiansen G; Hauptmann S; Schnorr D; Loening SA; Sinha P
Clin Chem; 2000 Jan; 46(1):47-54. PubMed ID: 10620571
[TBL] [Abstract][Full Text] [Related]
26. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.
Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH
Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a two-site immunoradiometric assay for measuring noncomplexed (free) prostate-specific antigen.
Cuny C; Pham L; Kramp W; Sharp T; Soriano TF
Clin Chem; 1996 Aug; 42(8 Pt 1):1243-9. PubMed ID: 8697584
[TBL] [Abstract][Full Text] [Related]
28. Impact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mL.
Berger AP; Cheli C; Levine R; Klocker H; Bartsch G; Horninger W
Urology; 2003 Nov; 62(5):840-4. PubMed ID: 14624905
[TBL] [Abstract][Full Text] [Related]
29. A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer.
Mitchell ID; Croal BL; Dickie A; Cohen NP; Ross I
J Urol; 2001 May; 165(5):1549-53. PubMed ID: 11342915
[TBL] [Abstract][Full Text] [Related]
30. Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology.
McDermed JE; Sanders R; Fait S; Klem RE; Sarno MJ; Adams TH; Diamandis EP
Clin Chem; 2012 Apr; 58(4):732-40. PubMed ID: 22361936
[TBL] [Abstract][Full Text] [Related]
31. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
[TBL] [Abstract][Full Text] [Related]
32. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
[TBL] [Abstract][Full Text] [Related]
33. Modified assay of prostate-specific antigen with a detection limit < 0.01 microgram/L.
Liedtke RJ; Kroon G; Batjer JD
Clin Chem; 1993 Oct; 39(10):2150-4. PubMed ID: 7691443
[TBL] [Abstract][Full Text] [Related]
34. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.
Stamey TA; Graves HC; Wehner N; Ferrari M; Freiha FS
J Urol; 1993 Apr; 149(4):787-92. PubMed ID: 7681119
[TBL] [Abstract][Full Text] [Related]
35. Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.
Jung K; Brux B; Lein M; Knäbich A; Sinha P; Rudolph B; Schnorr D; Loening SA
Urology; 1999 Jun; 53(6):1160-7; discussion 1167-8. PubMed ID: 10367846
[TBL] [Abstract][Full Text] [Related]
36. Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2.
Klee GG; Goodmanson MK; Jacobsen SJ; Young CY; Finlay JA; Rittenhouse HG; Wolfert RL; Tindall DJ
Clin Chem; 1999 Jun; 45(6 Pt 1):800-6. PubMed ID: 10351988
[TBL] [Abstract][Full Text] [Related]
37. Determination of non-alpha1-antichymotrypsin-complexed prostate-specific antigen as an indirect measurement of free prostate-specific antigen: analytical performance and diagnostic accuracy.
Wesseling S; Stephan C; Semjonow A; Lein M; Brux B; Sinha P; Loening SA; Jung K
Clin Chem; 2003 Jun; 49(6 Pt 1):887-94. PubMed ID: 12765984
[TBL] [Abstract][Full Text] [Related]
38. Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?
Jung K; Stephan C; Elgeti U; Lein M; Brux B; Kristiansen G; Rudolph B; Hauptmann S; Schnorr D; Loening SA; Sinha P
Int J Cancer; 2001 Sep; 93(5):759-65. PubMed ID: 11477592
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario.
Prestigiacomo AF; Lilja H; Pettersson K; Wolfert RL; Stamey TA
J Urol; 1996 Aug; 156(2 Pt 1):350-4. PubMed ID: 8683677
[TBL] [Abstract][Full Text] [Related]
40. Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
Wang TJ; Linton HJ; Payne J; Rittenhouse HG; Chan DW; Partin AW; Wolfert RL; Kuus-Reichel K
Hybridoma; 1999 Dec; 18(6):535-41. PubMed ID: 10626683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]